WO2006060203A3 - Imidazole derivatives for the treatment of dementia and related disorders - Google Patents

Imidazole derivatives for the treatment of dementia and related disorders Download PDF

Info

Publication number
WO2006060203A3
WO2006060203A3 PCT/US2005/042008 US2005042008W WO2006060203A3 WO 2006060203 A3 WO2006060203 A3 WO 2006060203A3 US 2005042008 W US2005042008 W US 2005042008W WO 2006060203 A3 WO2006060203 A3 WO 2006060203A3
Authority
WO
WIPO (PCT)
Prior art keywords
dementia
related disorders
treatment
imidazole derivatives
imidazole
Prior art date
Application number
PCT/US2005/042008
Other languages
French (fr)
Other versions
WO2006060203A2 (en
Inventor
Zahra Fathi
Original Assignee
Bayer Pharmaceuticals Corp
Zahra Fathi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp, Zahra Fathi filed Critical Bayer Pharmaceuticals Corp
Publication of WO2006060203A2 publication Critical patent/WO2006060203A2/en
Publication of WO2006060203A3 publication Critical patent/WO2006060203A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to imidazole derivatives which are useful in treating dementia and related disorders.
PCT/US2005/042008 2004-11-30 2005-11-18 Imidazole derivatives for the treatment of dementia and related disorders WO2006060203A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63202504P 2004-11-30 2004-11-30
US60/632,025 2004-11-30

Publications (2)

Publication Number Publication Date
WO2006060203A2 WO2006060203A2 (en) 2006-06-08
WO2006060203A3 true WO2006060203A3 (en) 2006-12-14

Family

ID=36565538

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/042008 WO2006060203A2 (en) 2004-11-30 2005-11-18 Imidazole derivatives for the treatment of dementia and related disorders

Country Status (1)

Country Link
WO (1) WO2006060203A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119963A1 (en) * 2000-07-31 2002-08-29 Sanner Mark A. Imidazole derivatives
US20040235854A1 (en) * 2001-09-21 2004-11-25 Kruse Cornelis G. 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
US20040248956A1 (en) * 2002-01-29 2004-12-09 Hagmann William K Substituted imidazoles as cannabinoid receptor modulators

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119963A1 (en) * 2000-07-31 2002-08-29 Sanner Mark A. Imidazole derivatives
US20040235854A1 (en) * 2001-09-21 2004-11-25 Kruse Cornelis G. 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
US20040248956A1 (en) * 2002-01-29 2004-12-09 Hagmann William K Substituted imidazoles as cannabinoid receptor modulators

Also Published As

Publication number Publication date
WO2006060203A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
WO2006071960A3 (en) Compositions and methods of treating cell proliferation disorders
ZA200700223B (en) Quinazolin-4-yl-piperidine and cinnolin-4-yl-peperidine derivatives as PDE10 inhibitors for the treatment of CNS disorders
WO2006024018A3 (en) Compositions for treating nociceptive pain
WO2006003388A3 (en) Compositions and methods for treating inflammatory disorders
AP2379A (en) Imidazole compounds for the treatment of neurodegenerative disorders.
WO2006119295A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
WO2006017384A3 (en) Indazoles useful in treating cardiovascular diseases
EP1893216A4 (en) Methods and compositions for the treatment of ocular disorders
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
IL179458A0 (en) Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
WO2008128072A3 (en) Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
ZA200700384B (en) Hydantoin derivatives for the treatment of inflammatory disorders
WO2007104053A3 (en) 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
WO2004078116A3 (en) P38 inhibitors and methods of use thereof
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2008073463A3 (en) Methods and compositions for treating and monitoring treatment of il-13-associated disorders
WO2006055871A3 (en) Treatment for multiple sclerosis
WO2007109037A3 (en) Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
GB2445674B (en) Compositions for the topical treatment of eczema, psoriasis and the like
WO2006135694A3 (en) Uii-modulating compounds and their use
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
TW200716561A (en) P38 inhibitors and methods of use thereof
WO2006078336A3 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
WO2004098599A3 (en) Proton pump inhibitors for the treatment of lower abdominal disorders

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05851889

Country of ref document: EP

Kind code of ref document: A2